WIP1 is a novel specific target for growth hormone action.

CHK2 phosphorylation was reduced in female acromegaly patients ∼35% (p < 0.05), but the reduction did not reach statistical significance in male patients with acromegaly ( Figure 1 E; Figure S1 E).

also in 111,027 other papers